Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo (Q36363994)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo |
scientific article |
Statements
1 reference
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo (English)
1 reference
B Ramaswamy
1 reference
W Fiskus
1 reference
B Cohen
1 reference
C Pellegrino
1 reference
D L Hershman
1 reference
E Chuang
1 reference
Thehang Luu
1 reference
G Somlo
1 reference
M Goetz
1 reference
R Swaby
1 reference
C L Shapiro
1 reference
V Stearns
1 reference
P Christos
1 reference
I Espinoza-Delgado
1 reference
K Bhalla
1 reference
J A Sparano
1 reference
27 December 2011
1 reference
1 reference
1063-1072
1 reference
Identifiers
1 reference
1 reference
1 reference